Loading page content…
Loading page content…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Award notice |
| Buyer: | The Royal Marsden NHS Foundation Trust |
| Main Category: | Services |
| Procurement Method: | Award procedure without prior publication of a call for competition |
| Tender Status: | Complete |
| Estimated Value (ex. VAT): | Not specified |
| Release Date: | 28 April 2025 |
| Application Deadline: | — |
| Procurement ID (OCID): | ocds-h6vhtk-05080f |
| Notice Reference: | 017198-2025 |
View Original Notice
Access the full notice on the official portal
SLA between NHS Blood & Transplant (supplier) and RMH (customer) for the the provision of Extracorporeal Photopheresis services for the treatment of chronic and acute Graft versus Host Disease (GvHD) and Cutaneous T-Cell Lymphoma. Extracorporeal photopheresis is a procedure which utilises an integrated closed system to collect white cells from the patient’s bloodstream. The cells are then treated with a photo activated drug and exposed to ultraviolet light before being returned to the patient.
Published contracts in the last 12 months
34
total contracts
£7.9m
total value
£1,126,000
average contract size
Typical categories
Prior Information Notice (PIN) for an innovation partnership to develop Artificial Intelligence (AI) in mammography
The Royal Marsden NHS Foundation Trust · WAC-148670
The Royal Marsden NHS Foundation Trust Magazine Design and Print
The Royal Marsden NHS Foundation Trust · WAC-148847
Pipeline status
Not addedContract imported automatically · AI writes the response
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →